The nonselective Ca 2+ -permeable transient receptor potential (TRP) channels play important roles in diverse cellular processes, including actin remodeling and cell migration. TRP channel subfamily C, member 5 (TRPC5) helps regulate a tight balance of cytoskeletal dynamics in podocytes and is suggested to be involved in the pathogenesis of proteinuric kidney diseases, such as focal segmental glomerulosclerosis (FSGS). As such, protection of podocytes by inhibition of TRPC5 mediated Ca 2+ signaling may provide a novel therapeutic approach for the treatment of proteinuric kidney diseases. Herein, we describe the identification of a novel TRPC5 inhibitor, GFB-8438, by systematic optimization of a high-throughput screening hit, pyridazinone 1. GFB-8438 protects mouse podocytes from injury induced by protamine sulfate (PS) in vitro. It is also efficacious in a hypertensive deoxycorticosterone acetate (DOCA)-salt rat model of FSGS, significantly reducing both total protein and albumin concentrations in urine.
The
clinical success of anti-IL-17 monoclonal antibodies (i.e.,
Cosentyx and Taltz) has validated Th17 pathway modulation for the
treatment of autoimmune diseases. The nuclear hormone receptor RORγt
is a master regulator of Th17 cells and affects the production of
a host of cytokines, including IL-17A, IL-17F, IL-22, IL-26, and GM-CSF.
Substantial interest has been spurred across both academia and industry
to seek small molecules suitable for RORγt inhibition. A variety
of RORγt inhibitors have been reported in the past few years,
the majority of which are orthosteric binders. Here we disclose the
discovery and optimization of a class of inhibitors, which bind differently
to an allosteric binding pocket. Starting from a weakly active hit 1, a tool compound 14 was quickly identified
that demonstrated superior potency, selectivity, and off-target profile.
Further optimization focused on improving metabolic stability. Replacing
the benzoic acid moiety with piperidinyl carboxylate, modifying the
4-aza-indazole core in 14 to 4-F-indazole, and incorporating
a key hydroxyl group led to the discovery of 25, which
possesses exquisite potency and selectivity, as well as an improved
pharmacokinetic profile suitable for oral dosing.
Herein, the sequential functionalization of 5-membered ring heterocycles is disclosed. By employing a pH sensitive directing group both directed and nondirected C-H activation pathways are available, providing access to 2,3,4- and 2,4,5-substituted thiophenes. The C-H arylation was performed in water, and using a surfactant greatly improved the yield and mass recovery. The use of a directing group with an on/off switch offers a potentially powerful means of generating diversity around medicinally relevant cores.
IntroductionDespite improvements in the medical and surgical management of infants with CHD, growth
failure before surgery in many infants continues to be a significant concern. A
nutritional pathway was developed, the aim of which was to provide a structured approach
to nutritional care for infants with CHD awaiting surgery.Materials and methodsThe modified Delphi process was development of a nutritional pathway; initial
stakeholder meeting to finalise draft guidelines and develop questions; round 1
anonymous online survey; round 2 online survey; regional cardiac conference and pathway
revision; and final expert meeting and pathway finalisation.ResultsPaediatric Dietitians from all 11 of the paediatric cardiology surgical centres in the
United Kingdom contributed to the guideline development. In all, 33% of participants had
9 or more years of experience working with infants with CHD. By the end of rounds 1 and
2, 76 and 96% of participants, respectively, were in agreement with the statements.
Three statements where consensus was not achieved by the end of round 2 were discussed
and agreed at the final expert group meeting.ConclusionsNutrition guidelines were developed for infants with CHD awaiting surgery, using a
modified Delphi process, incorporating the best available evidence and expert opinion
with regard to nutritional support in this group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.